Cost-utility analysis of the use of a wearable cardioverter defibrillator (LifeVest®) versus standard of care in the prevention of sudden cardiac death in patients after myocardial infarction

The strategy of preventing SCD through WCD usage proves to be cost-effective within the Polish healthcare context. The clinical benefits derived from WCD use justify the additional costs incurred, making it a viable option for SCD prevention in post-myocardial infarction patients in Poland.

Authors

Institutions

Publication Details

Journal
Kardiologia Polska
Published
2025-09-16
DOI
https://doi.org/10.33963/v.phj.108491
Primary Topic
Cardiac pacing and defibrillation studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cost-utility analysis of the use of a wearable cardioverter defibrillator (LifeVest®) versus standard of care in the prevention of sudden cardiac death in patients after myocardial infarction

Adam Wojtaszczyk, Oskar Kowalski, Andrzej Przybylski, Iwona Dobrowolska et al.
Kardiologia Polska
Cardiac pacing and defibrillation studies
article

Cost-utility analysis of the use of a wearable cardioverter defibrillator (LifeVest®) versus standard of care in the prevention of sudden cardiac death in patients after myocardial infarction

Adam Wojtaszczyk, Oskar Kowalski, Andrzej Przybylski, Iwona Dobrowolska, Katarzyna Młyńczak, Andrzej Ząbek, Łukasz Jan Szumowski, Maciej Kempa, Marek Gierlotka, Jerzy Krzysztof Wranicz, Michał M. Farkowski, Agnieszka Pawlak, Jarosław Kaźmierczak, Maciej Niewada, Marcin Michalak, Robert Gil, Paweł Ptaszyński, Maciej M. Sterlinski, Adam Sokal, Marcin Czech, Mateusz Tajstra, Przemysław Mitkowski, Adam Witkowski, Dominik Golicki
article en

Abstract

The strategy of preventing SCD through WCD usage proves to be cost-effective within the Polish healthcare context. The clinical benefits derived from WCD use justify the additional costs incurred, making it a viable option for SCD prevention in post-myocardial infarction patients in Poland.

Kardiologia PolskaVol. 83(11)
Warsaw University of Technology (PL), Poznan University of Medical Sciences (PL), Jagiellonian University (PL), Medical University of Silesia (PL), University of Opole (PL), Medical University of Warsaw (PL), John Paul II Hospital (PL), Medical University of Lodz (PL), Ministry of Interior and Administration (PL), Mother and Child Foundation (GB), Silesian Center for Heart Disease (PL), Institute of Cardiology (PL), Warsaw University of Technology Business School (PL), Mostostal Warszawa (Poland) (PL), Corona (Poland) (PL), Mossakowski Medical Research Institute, Polish Academy of Sciences (PL), Cardinal Stefan Wyszynski University in Warsaw (PL), Gdańsk Medical University (PL), Pomeranian Medical University (PL), University of Silesia in Katowice (PL), University of Rzeszów (PL), Polish Academy of Sciences (PL)
ZOLL Medical Corporation
Openalex Percentile: Top 62%
Cardiac pacing and defibrillation studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.